About Precise Biopharma Private Limited
Data last updated:
Precise Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC152453. Its GSTIN is 27AADCP8805E1ZF (Maharashtra). The company holds 8 GST registrations, of which 7 are active.
The company has an authorised share capital of ₹1.79 Cr and a paid-up capital of ₹1.79 Cr. It is led by directors including Mehul Pravin Shah and Sunil Sadanand Sukhathankar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 311 And E – 312 Eastern Business District Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹200.73 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹4.86 Cr (net margin 2.4%) and EBITDA of ₹16.25 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
The company has about 221 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Precise Group. As per MCA filings, the company has open charges of ₹56.92 Cr and satisfied charges of ₹4.75 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website precisegroup.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressE – 311 And E – 312 Eastern Business District Mumbai, Maharashtra, India – 400078
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Precise Biopharma Private Limited
Precise Biopharma operates one associated brand: Precise Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures APIs, intermediates, and finished formulations for healthcare markets worldwide. | precisegroup.co.in |
Competitors & Alternatives of Precise Biopharma Private Limited
Brands and companies operating in the same space as Precise Biopharma Private Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Concord Biotech | APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India | 2000 |
 BDR Pharmaceuticals Internationals | APIs and finished products are developed and manufactured. | Mumbai, India | 2003 |
 Almac Group | Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom | 2001 |
 Indoco Remedies | APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India | 1947 |
 Pharmaceutics International | Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States | 1994 |
 Aurobindo Pharma | Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India | 1986 |
 Seqens | Contract manufacturing services for small molecules and peptides are provided. | Ecully, France | 2003 |
 Asymchem | APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States | 1995 |
 Aptuit | Contract research and development services for small molecules are offered. | Greenwich, United States | 2004 |
 Continuus Pharma | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States | 2012 |
Business Activity of Precise Biopharma Private Limited
The main business activity of Precise Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Precise Biopharma Private Limited
Precise Biopharma Private Limited is audited by SKYCAP AND ASSOCIATES LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SKYCAP AND ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Precise Biopharma Private Limited
Precise Biopharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehul Pravin Shah | Director | 06 Apr 2005 | 21 Years 6 Months | Current |
| Sunil Sadanand Sukhathankar Also directs: Solasta Laboratories Private Limited | Director | 20 Aug 2021 | 5 Years 1 Months | Current |
| Rachana Mehul Shah | Additional Director | 20 Aug 2025 | 1 Years 1 Months | Current |
Financials of Precise Biopharma Private Limited FY 2024 filings available
Precise Biopharma Private Limited reported revenue of ₹200.73 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Precise Biopharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 18% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Precise Biopharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.25 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.86 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Precise Biopharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Precise Biopharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Precise Biopharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Precise Biopharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2025 | Others | ₹1.27 Cr | Open |
| 29 Feb 2024 | Others | ₹20 Lakh | Open |
| 05 Oct 2023 | Others | ₹9 Cr | Open |
| 31 Mar 2022 | Axis Bank Limited | ₹5 Cr | Open |
| 28 Jun 2021 | Hdfc Bank Limited | ₹8.02 Lakh | Open |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Precise Biopharma Private Limited
Precise Biopharma Private Limited has a workforce of 221 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Precise Biopharma Private Limited
Precise Biopharma has 8 GST registrations: 7 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCP8805E1ZF | Maharashtra | Active | 01 Jul 2017 |
| 05AADCP8805E1ZL | Uttarakhand | Active | 30 May 2019 |
| 02AADCP8805E2ZQ | Himachal Pradesh | Active | 10 Oct 2019 |
| 24AADCP8805E1ZL | Gujarat | Active | 22 Feb 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Precise Biopharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Precise Biopharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Precise Biopharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Precise Biopharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Precise Biopharma Private Limited
Frequently Asked Questions about Precise Biopharma Private Limited
Precise Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 April 2005 (21+ years old) and is registered under CIN U24230MH2005PTC152453.
Precise Biopharma reported revenue of ₹200.73 Cr for FY 2025 (up 18% YoY).
Precise Biopharma has 3 current directors:
- Mehul Pravin Shah - Director
- Sunil Sadanand Sukhathankar - Director
- Rachana Mehul Shah - Additional Director
Precise Biopharma reported a net profit of ₹4.86 Cr (net margin 2.4%) and EBITDA of ₹16.25 Cr (EBITDA margin 8.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Precise Biopharma is -5% over three years and 2% over five years. In the latest year (FY 2025) revenue rose 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Precise Biopharma is 27AADCP8805E1ZF, registered in Maharashtra. The company has 8 GST registrations in all, of which 7 are active and 1 is cancelled or inactive. Other active GSTINs include 05AADCP8805E1ZL (Uttarakhand), 02AADCP8805E2ZQ (Himachal Pradesh), 24AADCP8805E1ZL (Gujarat).
The CIN (Corporate Identification Number) of Precise Biopharma is U24230MH2005PTC152453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Precise Biopharma was incorporated on 06 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Precise Biopharma can be reached through the website precisegroup.co.in. Its registered office is in Mumbai, Maharashtra, India.